Dr. Ali Saeed Saad Alzahrani is a Consultant Endocrinologist at KFSHRC, leading the development of a comprehensive multidisciplinary Endocrine Oncology program encompassing thyroid, adrenal, pituitary, and neuroendocrine tumors.
His clinical and translational research focuses on thyroid cancer biology and therapeutics, genetic endocrinology, and the genomics of the adrenal gland, pancreas, parathyroid glands, hypothalamus, and pituitary, with a particular emphasis on Saudi-specific cohorts that leverage the region’s unique epidemiological landscape.
He has authored numerous peer-reviewed publications and collaborates extensively with national and international partners to integrate precision oncology into routine clinical care, including omics technologies, molecular tumor boards, and biobanking. He has also led multidisciplinary initiatives aimed at expanding access to care, standardizing molecular testing workflows, and accelerating the translation of research discoveries from bench to bedside.
His current projects include Saudi cohort studies in endocrine oncology, optimization of targeted therapies for radioiodine-refractory thyroid cancer, anaplastic thyroid cancer and advanced genomic investigations of pituitary and adrenal tumors. He is deeply committed to workforce development through the mentorship of clinical medical fellows within the Endocrine Oncology Program, as well as PhD and Master’s students in Molecular Endocrinology, and to the establishment of sustainable research infrastructure aligned with national health and innovation priorities.